Protein Identified as a Driver of Acute Myeloid Leukemia, Inhibition Shows Therapeutic Efficacy - Technology Networks
Protein Identified as a Driver of Acute Myeloid Leukemia, Inhibition Shows Therapeutic Efficacy Technology Networks
Leukemia News
Effingham County community rallies around 9-year-old boy diagnosed with leukemia - WTOC
Effingham County community rallies around 9-year-old boy diagnosed with leukemia WTOC
FDA Approves Oral Combination for Older Adults with Acute Myeloid Leukemia - Oncology News Central
FDA Approves Oral Combination for Older Adults with Acute Myeloid Leukemia Oncology News Central
Marine Corps Veteran, 35, Awaits Lifesaving Stem Cell Transplant: 'I'm Ready' (Exclusive) - People.com
Marine Corps Veteran, 35, Awaits Lifesaving Stem Cell Transplant: 'I'm Ready' (Exclusive) People.com
Leukemia patient with less than 50% match rate calls for more diverse stem cell donors - KTVU
Leukemia patient with less than 50% match rate calls for more diverse stem cell donors KTVU
SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses - Yahoo Finance
SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses Yahoo Finance
Advances in acute leukemia: new therapies and clinical trials - Penn Medicine
Advances in acute leukemia: new therapies and clinical trials Penn Medicine
Local oxygen tension dictates hematopoietic cell growth and potency - Nature
Local oxygen tension dictates hematopoietic cell growth and potency Nature
Cats with feline leukemia virus seek forever homes at the CASPCA - WVIR
Cats with feline leukemia virus seek forever homes at the CASPCA WVIR
Leukemia: What Primary Care Physicians Need to Know - American Academy of Family Physicians | AAFP
Leukemia: What Primary Care Physicians Need to Know American Academy of Family Physicians | AAFP
New FUSILLI tool improves gene fusion detection in pediatric leukemia - news-medical.net
New FUSILLI tool improves gene fusion detection in pediatric leukemia news-medical.net
FDA Approves First All-Oral Regimen for AML - AJMC
FDA Approves First All-Oral Regimen for AML AJMC
Community fundraiser in Anthony helps sixth grader Camilo battle leukemia - KFOX
Community fundraiser in Anthony helps sixth grader Camilo battle leukemia KFOX
Annamycin Plus Cytarabine Delivers Promising Response Rates in R/R AML - OncLive
Annamycin Plus Cytarabine Delivers Promising Response Rates in R/R AML OncLive
This Week’s CGT News: Novo’s Parkinson’s Pivot - Conexiant
This Week’s CGT News: Novo’s Parkinson’s Pivot Conexiant
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ - UT MD Anderson
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ UT MD Anderson
FDA OKs all-oral therapy for AML patients not eligible for chemo - Rare Cancer News
FDA OKs all-oral therapy for AML patients not eligible for chemo Rare Cancer News
Large Granular Lymphocytic Leukemia Market is Projected - openPR.com
Large Granular Lymphocytic Leukemia Market is Projected openPR.com
Effingham County community rallies around 9-year-old boy diagnosed with leukemia - WTOC
Effingham County community rallies around 9-year-old boy diagnosed with leukemia WTOC
49-year leukemia survivor: Why I support immunotherapy research at UT MD Anderson - UT MD Anderson
49-year leukemia survivor: Why I support immunotherapy research at UT MD Anderson UT MD Anderson
Acton Police, Cops for Kids with Cancer rally behind 3-year-old battling leukemia - Lowell Sun
Acton Police, Cops for Kids with Cancer rally behind 3-year-old battling leukemia Lowell Sun
Understanding acute myeloid leukemia - Servier
Understanding acute myeloid leukemia Servier
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D | Leukemia - Nature
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D | Leukemia Nature
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia The New England Journal of Medicine
Yale-Led Study Identifies a New Target for Treating Acute Leukemia - Yale School of Medicine
Yale-Led Study Identifies a New Target for Treating Acute Leukemia Yale School of Medicine
Leukemia Breakthroughs Are Helping Patients Live Longer - City of Hope
Leukemia Breakthroughs Are Helping Patients Live Longer City of Hope
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data - Nature
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data Nature
Rahul Banerjee: Leukemia Approval of Daratumumab as Early Intervention Marks a Pivotal Moment - Oncodaily
Rahul Banerjee: Leukemia Approval of Daratumumab as Early Intervention Marks a Pivotal Moment Oncodaily
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology) - Nature
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology) Nature
Sylvester’s Researchers Lead Major Treatment Overhauls For Acute Myeloid Leukemia - University of Miami
Sylvester’s Researchers Lead Major Treatment Overhauls For Acute Myeloid Leukemia University of Miami
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia - The New England Journal of Medicine
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia The New England Journal of Medicine
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia - Nature
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia Nature
Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia - Yale School of Medicine
Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia Yale School of Medicine
Leukemia drug secures FDA approval - michiganmedicine.org
Leukemia drug secures FDA approval michiganmedicine.org
WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy - WVU Medicine
WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy WVU Medicine
Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries - The New England Journal of Medicine
Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries The New England Journal of Medicine
CRISPR-based platform pinpoints drivers of leukemia in patient cells - Penn Medicine
CRISPR-based platform pinpoints drivers of leukemia in patient cells Penn Medicine
9-year-old battling leukemia holds blood drive for other kids - WUSA9
9-year-old battling leukemia holds blood drive for other kids WUSA9
New nanomedicine wipes out leukemia in animal study - Northwestern Now News
New nanomedicine wipes out leukemia in animal study Northwestern Now News
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia - Nature
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia Nature